Clinical significance of lncRNA BCYRN1 in colorectal cancer and its role in cell metastasis.
To explore the expression of long non-coding RNA (lncRNA) BCYRN1 and its clinical significance and function in colorectal cancer (CRC). Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the expression of lncRNA BCYRN1 in CRC tissues and cells. The relationship between lncRNA BCYRN1 expression and CRC clinicopathological characteristics was statistically analyzed. Furthermore, the Kaplan-Meier curve was performed in survival analysis. In vitro study, transwell and Western blot assays were used to detect the metastasis ability of CRC cells. LncRNA BCYRN1 expression was markedly up-regulated in CRC; high expression of lncRNA BCYRN1 promoted tumor metastasis in CRC patients and suggested a poor prognosis. In vitro study, down-regulation of lncRNA BCYRN1 expression by si-BCYRN1 could significantly inhibit invasion and migration of CRC cells. LncRNA BCYRN1 was a novel factor involved in CRC progression, and constituted a potential biomarker and therapeutic target for the patients.